Microbiology technology, equipment and consumables market to reach $13.24 billion by 2030 at 11.3% CAGR, driven by increasing hospital-acquired infection rates.
Read More
Microbial sealant market to reach $4.16 billion by 2030 at 8.1% CAGR, driven by increasing number of surgeries and surging number of sports injuries.
Read More
Microbial api market to reach $95.49 billion by 2030 at 7.0% CAGR, driven by rising prevalence of chronic conditions.
Read More
Mexiletine hydrochloride market to reach $1.93 billion by 2030 at 8.4% CAGR, driven by increasing number of cardiovascular diseases.
Read More
Metronidazole market to reach $0.8 billion by 2030 at 5.5% CAGR, driven by increasing incidence of bacterial infections.
Read More
Methylsulfonylmethane (msm) supplements market to reach $2.07 billion by 2030 at 8.9% CAGR, driven by increase in prevalence of joint disorders and rise in aging population.
Read More
Methicillin-resistant staphylococcus aureus (mrsa) drugs market to reach $3.25 billion by 2030 at 6.0% CAGR, driven by rising hospital acquired infections.
Read More
Methenamine hippurate tablets market to reach $14.49 billion by 2030 at 7.5% CAGR, driven by rising cases of urinary tract infections and rising healthcare expenditure.
Read More
Metastatic cancer drugs market to reach $79.32 billion by 2030 at 5.8% CAGR, driven by evolution of precision medicine and personalized therapies.
Read More
Messenger ribonucleic acid quality monitoring market to reach $2.49 billion by 2030 at 11.0% CAGR, driven by increasing demand for personalized medicines.
Read More